A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

The age of artificial intelligence (AI) is truly upon us, and we are experiencing the impact of AI across nearly every ...

Upstream Bio (NASDAQ:UPB) reported top-line results from its Phase II VALIANT trial evaluating verekitug in adults with ...

Mold is a silent threat, often going unnoticed as it quietly harms health. What's concerning is that exposure to mold during ...

The frenzy of new data center construction has opened the door to using much larger and higher levels of abstractions — massive multi-physics simulations and real-time monitoring of everything from ...

International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease ...

Lightweight portable system delivers fast, precise, objective data for rapid aid in diagnosis of concussions in ...

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes ...

Empowering HR leaders with intelligent digital solutions has become essential in responding to evolving workforce ...

Mydbops announces its strategic focus on Database Reliability Engineering to help SaaS companies improve database ...

After an analysis of health data from over 131,000 people tracked for up to 43 years, researchers found that drinking coffee ...

In an interview, Jackson Peter Kim, MD, clinical assistant professor in the Division of Nephrology at Stanford Health Care, ...